SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-20-122993
Filing Date
2020-04-28
Accepted
2020-04-28 16:01:07
Documents
4
Period of Report
2020-06-17
Effectiveness Date
2020-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A d914407ddef14a.htm DEF 14A 745597
2 GRAPHIC g914407g45a81.jpg GRAPHIC 32310
3 GRAPHIC g914407g55b18.jpg GRAPHIC 7159
4 GRAPHIC g914407g69b64.jpg GRAPHIC 91111
  Complete submission text file 0001193125-20-122993.txt   926713
Mailing Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Filer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37539 | Film No.: 20824850
SIC: 2834 Pharmaceutical Preparations